These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 36098769)

  • 1. New-onset systemic lupus erythematosus following BNT162b2 mRNA COVID-19 vaccine: a case series and literature review.
    Sagy I; Zeller L; Raviv Y; Porges T; Bieber A; Abu-Shakra M
    Rheumatol Int; 2022 Dec; 42(12):2261-2266. PubMed ID: 36098769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic lupus erythematosus with acute pancreatitis and vasculitic rash following COVID-19 vaccine: a case report and literature review.
    N AM; Saleh AM; Khalid A; Alshaya AK; Alanazi SMM
    Clin Rheumatol; 2022 May; 41(5):1577-1582. PubMed ID: 35175446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local and systemic reactogenicity of COVID-19 vaccine BNT162b2 in patients with systemic lupus erythematosus and rheumatoid arthritis.
    Bartels LE; Ammitzbøll C; Andersen JB; Vils SR; Mistegaard CE; Johannsen AD; Hermansen MF; Thomsen MK; Erikstrup C; Hauge EM; Troldborg A
    Rheumatol Int; 2021 Nov; 41(11):1925-1931. PubMed ID: 34476603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic lupus erythematosus myocarditis after COVID-19 vaccination.
    Sogbe M; Blanco-Di Matteo A; Di Frisco IM; Bastidas JF; Salterain N; Gavira JJ
    Reumatol Clin (Engl Ed); 2023 Feb; 19(2):114-116. PubMed ID: 36739118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optic Neuritis Following the BNT162b2 mRNA COVID-19 Vaccine in a Patient with Systemic Lupus Erythematosus Uncovering the Diagnosis of Neuromyelitis Optica Spectrum Disorders.
    Shirah B; Mulla I; Aladdin Y
    Ocul Immunol Inflamm; 2023 Aug; 31(6):1213-1215. PubMed ID: 35849732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiomyopathy following COVID-19 vaccination in a patient with systemic lupus erythematosus.
    Bhullar AK; Chew ZC; Ong PS; Khor CG; Mohd Amin NH
    Mod Rheumatol Case Rep; 2023 Jan; 7(1):87-91. PubMed ID: 36069645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features of newly diagnosed systemic lupus erythematosus after SARS-CoV-2 vaccination.
    Moriyama M; Noda K; Ito H; Matsushita T; Kurosaka D
    Mod Rheumatol Case Rep; 2023 Dec; 8(1):63-68. PubMed ID: 37348045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic lupus erythematosus following COVID-19 vaccination. A systematic review of case reports and case series.
    Cahuapaza-Gutierrez NL
    Lupus; 2024 Apr; 33(4):375-386. PubMed ID: 38315894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herpes zoster following BNT162b2 mRNA COVID-19 vaccination in patients with autoimmune inflammatory rheumatic diseases: a case series.
    Furer V; Zisman D; Kibari A; Rimar D; Paran Y; Elkayam O
    Rheumatology (Oxford); 2021 Oct; 60(SI):SI90-SI95. PubMed ID: 33848321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Side effects and flares risk after SARS-CoV-2 vaccination in patients with systemic lupus erythematosus.
    Zavala-Flores E; Salcedo-Matienzo J; Quiroz-Alva A; Berrocal-Kasay A
    Clin Rheumatol; 2022 May; 41(5):1349-1357. PubMed ID: 34782941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medium-term impact of the SARS-CoV-2 mRNA vaccine against disease activity in patients with systemic lupus erythematosus.
    Yoshida T; Tsuji H; Onishi A; Takase Y; Shirakashi M; Onizawa H; Hiwa R; Kitagori K; Akizuki S; Nakashima R; Tanaka M; Yoshifuji H; Morinobu A
    Lupus Sci Med; 2022 Aug; 9(1):. PubMed ID: 35961691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 vaccines in patients with SLE.
    Tang W; Askanase AD; Khalili L; Merrill JT
    Lupus Sci Med; 2021 Mar; 8(1):. PubMed ID: 33685998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New-onset Evans syndrome associated with systemic lupus erythematosus after BNT162b2 mRNA COVID-19 vaccination.
    Hidaka D; Ogasawara R; Sugimura S; Fujii F; Kojima K; Nagai J; Ebata K; Okada K; Kobayashi N; Ogasawara M; Imamura M; Ota S
    Int J Hematol; 2022 Mar; 115(3):424-427. PubMed ID: 34687421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous lupus-erythematosus-like reaction arising after COVID-19 vaccination.
    Rose C; Apgar R; Green M
    J Cutan Pathol; 2022 Nov; 49(11):943-946. PubMed ID: 35754159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and tolerance of vaccines against SARS-CoV-2 infection in systemic lupus erythematosus: results from the COVAD study.
    Naveen R; Nikiphorou E; Joshi M; Sen P; Lindblom J; Agarwal V; Lilleker JB; Tan AL; Salim B; Ziade N; Velikova T; Gracia-Ramos AE; Kuwana M; Day J; Makol A; Distler O; Chinoy H; Traboco LS; Wibowo SAK; Tehozol EAZ; Serrano JR; García-De La Torre I; ; Aggarwal R; Gupta L; Agarwal V; Parodis I
    Rheumatology (Oxford); 2023 Jul; 62(7):2453-2463. PubMed ID: 36413073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 12-month follow-up study of patients with systemic lupus erythematosus after immunization against SARS-CoV-2.
    Zavala-Flores E; Salcedo-Matienzo J; Huamanchumo-Guzman R; Berrocal-Kasay A; Alarcón GS
    Lupus; 2024 Mar; 33(3):282-288. PubMed ID: 38237938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The third dose of BNT162b2 COVID-19 vaccine is efficacious and safe for systemic lupus erythematosus patients receiving belimumab.
    Tunitsky-Lifshitz Y; Maoz-Segal R; Niznik S; Shavit R; Haj Yahia S; Langevitz P; Agmon-Levin N
    Lupus; 2023 Apr; 32(5):675-679. PubMed ID: 36952594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 vaccine safety during pregnancy in women with systemic lupus erythematosus.
    Giannopoulou N; Gupta L; Andreoli L; Lini D; ; Nikiphorou E; Aggarwal R; Agarwal V; Parodis I
    Autoimmun Rev; 2023 Apr; 22(4):103292. PubMed ID: 36740090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New-onset of rheumatic diseases following COVID-19 vaccination: the report of three cases and a literature review.
    Matsuda M; Funakubo Asanuma Y; Emoto K; Sakai S; Okumura N; Yazawa H; Maruyama T; Tsuzuki Wada T; Yokota K; Araki Y; Akiyama Y; Mimura T
    Immunol Med; 2024 Sep; 47(3):205-216. PubMed ID: 38627989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired innate and adaptive immune responses to BNT162b2 SARS-CoV-2 vaccination in systemic lupus erythematosus.
    Sarin KY; Zheng H; Chaichian Y; Arunachalam PS; Swaminathan G; Eschholz A; Gao F; Wirz OF; Lam B; Yang E; Lee LW; Feng A; Lewis MA; Lin J; Maecker HT; Boyd SD; Davis MM; Nadeau KC; Pulendran B; Khatri P; Utz PJ; Zaba LC
    JCI Insight; 2024 Mar; 9(5):. PubMed ID: 38456511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.